M&A Deal Summary

Core One Labs Acquires Rainy Daze Cannabis

On October 23, 2019, Core One Labs acquired agriculture company Rainy Daze Cannabis

Acquisition Highlights
  • This is Core One Labs’ 1st transaction in the Agriculture sector.
  • This is Core One Labs’ 1st transaction in Canada.
  • This is Core One Labs’ 1st transaction in British Columbia.

M&A Deal Summary

Date 2019-10-23
Target Rainy Daze Cannabis
Sector Agriculture
Buyer(s) Core One Labs
Deal Type Add-on Acquisition

Target

Rainy Daze Cannabis

British Columbia, Canada
Rainy Daze was organized by the CEO of a fully-licensed Canadian LP with current Cultivation and Medical Sales licenses. Rainy Daze facility has a license application in process. The facility used by Rainy Daze is held under a long term lease and is currently under construction, once completed, the facility will include 22,510 sq. ft. of canopy space and 3,500 sq. ft. of operational purpose-built building.

Search 200,291 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Core One Labs

Vancouver, British Columbia, Canada

Category Company
Founded 2010
Sector Consumer Products
Revenue 1M USD (2022)
DESCRIPTION

Core One Labs is a technology company that licenses its technology to a state-of-the-art production and packaging facility located in Southern California. The Company's technology produces infused strips (similar to breath strips) that are not only a safer, healthier option to other forms of delivery but also superior bioavailability of cannabis constituents. Some strips will also include supplemental co-active ingredients such as nutraceuticals, vitamins and peptides. The technology provides a new way to accurately meter the dosage and assure the purity of selected product. Core One Labs was founded in 2010 and is based in Vancouver, British Columbia.


DEAL STATS #
Overall 1 of 4
Sector (Agriculture) 1 of 1
Type (Add-on Acquisition) 1 of 4
State (British Columbia) 1 of 2
Country (Canada) 1 of 3
Year (2019) 1 of 1
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2021-04-29 Akome Biotech

United States

Akome Biotech develops psychedelic-based pharmaceuticals to help patients overcome specific illnesses.

Buy -